Persistent Asset Partners Ltd Portfolio Stock Holdings
According to the SEC 13F filed on August 7, 2026, Persistent Asset Partners Ltd disclosed 703 stock positions valued at approximately $316.95M as of quarter-end June 30, 2026. The largest holdings include INTEL CORP, ROBINHOOD MKTS INC, and STMICROELECTRONICS N V.
- Report Period
- June 30, 2026
- No. of Stocks
- 703
- Portfolio Value
- $316.95M
Holdings by Sector
Persistent Asset Partners Ltd Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| INTEL CORP | INTC | Technology | 7.63% | 173,113 | -101,276 | -36.91% | $24,171,769 |
| ROBINHOOD MKTS INC | HOOD | Financial Services | 6.05% | 191,095 | +184,476 | +2787.07% | $19,163,007 |
| STMICROELECTRONICS N V | STM | Technology | 5.33% | 225,636 | +225,636 | +100.00% | $16,897,880 |
| AMPHENOL CORP | APH | Technology | 4.20% | 75,502 | +75,502 | +100.00% | $13,312,513 |
| SEAGATE TECHNOLOGY HLDNGS PL | STX | Other | 2.82% | 9,265 | +9,265 | +100.00% | $8,940,725 |
| UNITED THERAPEUTICS CORP DEL | UTHR | Healthcare | 2.39% | 13,981 | +7,079 | +102.56% | $7,575,325 |
| REVOLUTION MEDICINES INC | RVMD | Healthcare | 2.29% | 38,726 | +12,683 | +48.70% | $7,252,605 |
| SNOWFLAKE INC | SNOW | Technology | 2.23% | 27,783 | +27,783 | +100.00% | $7,070,774 |
| FORD MTR CO | F | Consumer Cyclical | 1.96% | 445,837 | +445,837 | +100.00% | $6,197,134 |
| ABIVAX SA | ABVX | Healthcare | 1.86% | 44,256 | +21,418 | +93.78% | $5,897,555 |
| APPLIED MATLS INC | AMAT | Technology | 1.77% | 7,780 | +7,780 | +100.00% | $5,624,940 |
| COGENT BIOSCIENCES INC | COGT | Healthcare | 1.69% | 138,272 | +45,756 | +49.46% | $5,351,127 |
| KLA CORP | KLAC | Technology | 1.57% | 16,442 | +16,442 | +100.00% | $4,960,716 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | Healthcare | 1.44% | 79,933 | +42,461 | +113.31% | $4,573,766 |
| VIKING THERAPEUTICS INC | VKTX | Healthcare | 1.39% | 112,736 | -20,330 | -15.28% | $4,397,831 |
| CADENCE DESIGN SYSTEM INC | CDNS | Technology | 1.32% | 11,111 | +11,111 | +100.00% | $4,170,181 |
| LAM RESEARCH CORP | LRCX | Other | 1.21% | 8,824 | +5,763 | +188.27% | $3,823,704 |
| SEMTECH CORP | SMTC | Technology | 1.12% | 21,849 | -9,506 | -30.32% | $3,536,261 |
| HONEYWELL INTL INC | HON | Other | 1.09% | 15,450 | +15,450 | +100.00% | $3,459,255 |
| HONEYWELL AEROSPACE INC | HONA | Other | 1.08% | 15,450 | +15,450 | +100.00% | $3,415,686 |
| WESTERN DIGITAL CORP | WDC | Technology | 0.98% | 4,859 | +4,859 | +100.00% | $3,103,540 |
| SANDISK CORP | SNDK | Other | 0.98% | 1,360 | -12,920 | -90.48% | $3,092,273 |
| EDGEWISE THERAPEUTICS INC | EWTX | Healthcare | 0.89% | 69,441 | +59,388 | +590.75% | $2,821,388 |
| LITTELFUSE INC | LFUS | Technology | 0.85% | 5,927 | +5,927 | +100.00% | $2,698,741 |
| CORNING INC | GLW | Technology | 0.75% | 9,368 | -49,720 | -84.15% | $2,392,868 |
| MICRON TECHNOLOGY INC | MU | Technology | 0.75% | 2,053 | -14,497 | -87.60% | $2,369,757 |
| ONTO INNOVATION INC | ONTO | Technology | 0.71% | 5,947 | +5,947 | +100.00% | $2,250,642 |
| KODIAK SCIENCES INC | KOD | Healthcare | 0.69% | 56,052 | +4,716 | +9.19% | $2,183,786 |
| TRIPADVISOR INC | TRIP | Consumer Cyclical | 0.69% | 158,456 | +58,456 | +58.46% | $2,172,431 |
| PDD HOLDINGS INC | PDD | Consumer Cyclical | 0.68% | 28,145 | +13,413 | +91.05% | $2,146,900 |
Showing 30 of 703 holdings in the latest reporting period.
Persistent Asset Partners Ltd Options Holdings in Q2 2026
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q2 2026 | VKTX | Viking Therapeutics, Inc. | CALL | 3,105 | $2,266,358 |
| Q2 2026 | ABVX | Abivax SA | CALL | 890 | $2,068,986 |
| Q2 2026 | CORT | Corcept Therapeutics Incorporat | CALL | 524 | $1,552,197 |
| Q2 2026 | KYMR | Kymera Therapeutics, Inc. | CALL | 381 | $1,024,082 |
| Q2 2026 | QURE | uniQure N.V. | CALL | 596 | $982,565 |
| Q2 2026 | SLS | SELLAS Life Sciences Group, Inc | CALL | 1,013 | $852,895 |
| Q2 2026 | CAPR | Capricor Therapeutics, Inc. | CALL | 831 | $697,076 |
| Q2 2026 | SMMT | Summit Therapeutics Inc. | CALL | 2,194 | $519,509 |
| Q2 2026 | TENX | Tenax Therapeutics, Inc. | CALL | 782 | $481,328 |
| Q2 2026 | ALMS | Alumis Inc. | CALL | 508 | $443,667 |
| Q2 2026 | CAPR | Capricor Therapeutics, Inc. | PUT | 1,356 | $404,940 |
| Q2 2026 | REPL | Replimune Group, Inc. | CALL | 1,774 | $396,972 |
| Q2 2026 | KOD | Kodiak Sciences Inc | PUT | 372 | $344,930 |
| Q2 2026 | BIOA | BIOAGE LABS INC | CALL | 510 | $342,710 |
| Q2 2026 | CRVS | Corvus Pharmaceuticals, Inc. | CALL | 340 | $274,383 |
| Q2 2026 | GLUE | Monte Rosa Therapeutics, Inc. | CALL | 434 | $258,066 |
| Q2 2026 | PCVX | Vaxcyte, Inc. | CALL | 135 | $248,565 |
| Q2 2026 | BMY | Bristol-Myers Squibb Company | CALL | 1,535 | $243,583 |
| Q2 2026 | CRBP | Corbus Pharmaceuticals Holdings | CALL | 1,615 | $235,063 |
| Q2 2026 | KOD | Kodiak Sciences Inc | CALL | 502 | $215,919 |
| Q2 2026 | ANNX | Annexon, Inc. | CALL | 897 | $206,640 |
| Q2 2026 | NVO | Novo Nordisk A/S | PUT | 143 | $195,994 |
| Q2 2026 | EYPT | EyePoint Pharmaceuticals, Inc. | CALL | 269 | $186,441 |
| Q2 2026 | HIMS | Hims & Hers Health, Inc. | CALL | 510 | $185,125 |
| Q2 2026 | NTLA | Intellia Therapeutics, Inc. | CALL | 512 | $171,981 |
| Q2 2026 | BIIB | Biogen Inc. | CALL | 154 | $168,507 |
| Q2 2026 | INCY | Incyte Corporation | PUT | 266 | $159,044 |
| Q2 2026 | REPL | Replimune Group, Inc. | PUT | 1,280 | $115,200 |
| Q2 2026 | VKTX | Viking Therapeutics, Inc. | PUT | 894 | $114,298 |
| Q2 2026 | BNTX | BioNTech SE | CALL | 255 | $110,632 |
Showing 30 of 89 options positions in the latest reporting period.
Notional value represents the total exposure of the options position.